NO903532L - Fremgangsmaate for behandling av kardiell, saavel som vaskulaer hypertropi og hyperplasi. - Google Patents

Fremgangsmaate for behandling av kardiell, saavel som vaskulaer hypertropi og hyperplasi.

Info

Publication number
NO903532L
NO903532L NO90903532A NO903532A NO903532L NO 903532 L NO903532 L NO 903532L NO 90903532 A NO90903532 A NO 90903532A NO 903532 A NO903532 A NO 903532A NO 903532 L NO903532 L NO 903532L
Authority
NO
Norway
Prior art keywords
treatment
administration
vasculas
hyperplasy
cardially
Prior art date
Application number
NO90903532A
Other languages
English (en)
Other versions
NO903532D0 (no
NO306979B1 (no
Inventor
Wolfgang Linz
Bernward Schoelkens
Wolfgang Scholz
Gabriele Wiemer
Hansjoerg Urbach
Rainer Henning
Volker Teetz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6386970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO903532(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO903532D0 publication Critical patent/NO903532D0/no
Publication of NO903532L publication Critical patent/NO903532L/no
Publication of NO306979B1 publication Critical patent/NO306979B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Crucibles And Fluidized-Bed Furnaces (AREA)
  • Preliminary Treatment Of Fibers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Element Separation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO903532A 1989-08-11 1990-08-10 Fremgangsmåte for fremstilling av et farmasoeytisk preparat for behandling av kardial så vel som vaskulaer hypertrofi og hyperplasi NO306979B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3926606A DE3926606A1 (de) 1989-08-11 1989-08-11 Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie

Publications (3)

Publication Number Publication Date
NO903532D0 NO903532D0 (no) 1990-08-10
NO903532L true NO903532L (no) 1991-02-12
NO306979B1 NO306979B1 (no) 2000-01-24

Family

ID=6386970

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903532A NO306979B1 (no) 1989-08-11 1990-08-10 Fremgangsmåte for fremstilling av et farmasoeytisk preparat for behandling av kardial så vel som vaskulaer hypertrofi og hyperplasi

Country Status (22)

Country Link
US (1) US5231083A (no)
EP (1) EP0417473B1 (no)
JP (1) JP3452199B2 (no)
KR (1) KR0185969B1 (no)
AT (1) ATE94409T1 (no)
AU (1) AU631914B2 (no)
CA (1) CA2023089C (no)
CS (1) CS277644B6 (no)
DD (1) DD297063A5 (no)
DE (2) DE3926606A1 (no)
DK (1) DK0417473T3 (no)
ES (1) ES2059931T3 (no)
FI (1) FI903936A7 (no)
HU (1) HU205008B (no)
IE (1) IE64604B1 (no)
IL (1) IL95327A (no)
NO (1) NO306979B1 (no)
NZ (1) NZ234836A (no)
PH (1) PH30831A (no)
PL (1) PL286442A1 (no)
PT (1) PT94957B (no)
ZA (1) ZA906327B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643911A (en) 1994-05-19 1997-07-01 Mitsubishi Chemical Corporation Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia
SG68529A1 (en) * 1995-05-25 1999-11-16 Univ Singapore The use of des-aspartate-angiotensin i (agr-val-tyr-ile-his-pro-phe-his-leu) as an anti-cardiac hypertrophic agent
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
HUP0203326A3 (en) * 1999-08-30 2003-04-28 Sanofi Aventis Deutschland Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
US6395767B2 (en) * 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
WO2006052968A2 (en) * 2004-11-05 2006-05-18 King Pharmaceuticals Research & Development, Inc. Stabilized ramipril compositions and methods of making
EP2642998B1 (en) 2010-11-24 2020-09-16 The Trustees of Columbia University in the City of New York A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
WO2013166037A1 (en) 2012-05-01 2013-11-07 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of eye disorders
ES2700541T3 (es) 2013-03-14 2019-02-18 Univ Columbia Octahidrociclopentapirroles, su preparación y uso
WO2014151936A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles, their preparation and use
US9938291B2 (en) 2013-03-14 2018-04-10 The Trustess Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
WO2014152013A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York 4-phenylpiperidines, their preparation and use
DK4036094T3 (da) 2014-04-30 2026-03-23 Univ Columbia Erstattede 4-fenylpiperidiner, deres fremstilling og anvendelse

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4311705A (en) * 1980-10-06 1982-01-19 E. R. Squibb & Sons, Inc. Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines
US4337201A (en) * 1980-12-04 1982-06-29 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted prolines
US4381297A (en) * 1981-05-04 1983-04-26 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
US4602002A (en) * 1983-02-07 1986-07-22 Merck & Co., Inc. N-carboxymethyl substituted lysyl and α-(ε-aminoalkyl) glycyl amino acid antihypertensive agents
US4548941A (en) * 1984-07-30 1985-10-22 Merck & Co., Inc. 1,5-Methano-1H-4-benzazonine dicarboxylates, process for preparing and use as calcium blockers
US4587253A (en) * 1984-07-30 1986-05-06 Merck & Co., Inc. Bridged pyridine compounds useful as calcium channel blockers and analgesics
US4599341A (en) * 1984-10-01 1986-07-08 Merck & Co., Inc. Substituted and bridged pyridines useful as calcium channel blockers
US4656188A (en) * 1985-10-09 1987-04-07 Merck & Co., Inc. Ace inhibitors in macular degeneration
DE3705220A1 (de) * 1987-02-19 1988-09-01 Boehringer Ingelheim Kg Mittel zur behandlung von coronarerkrankungen oder organischem hirnsyndrom
ZA896851B (en) * 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors

Also Published As

Publication number Publication date
DE3926606A1 (de) 1991-02-14
NO903532D0 (no) 1990-08-10
AU631914B2 (en) 1992-12-10
US5231083A (en) 1993-07-27
ES2059931T3 (es) 1994-11-16
IL95327A0 (en) 1991-06-30
IE64604B1 (en) 1995-08-23
CS277644B6 (en) 1993-03-17
HU205008B (en) 1992-03-30
ATE94409T1 (de) 1993-10-15
KR910004189A (ko) 1991-03-28
DE59002721D1 (de) 1993-10-21
IE902910A1 (en) 1991-02-27
CS395890A3 (en) 1992-08-12
FI903936A0 (fi) 1990-08-09
KR0185969B1 (ko) 1999-05-01
PT94957A (pt) 1991-05-22
PL286442A1 (en) 1992-03-09
CA2023089A1 (en) 1991-02-12
EP0417473A1 (de) 1991-03-20
CA2023089C (en) 2003-01-14
NO306979B1 (no) 2000-01-24
DD297063A5 (de) 1992-01-02
FI903936A7 (fi) 1991-02-12
JP3452199B2 (ja) 2003-09-29
HUT54504A (en) 1991-03-28
ZA906327B (en) 1991-05-29
JPH0383957A (ja) 1991-04-09
AU6092090A (en) 1991-02-14
DK0417473T3 (da) 1993-12-13
NZ234836A (en) 1997-05-26
PT94957B (pt) 1997-05-28
PH30831A (en) 1997-10-17
HU904966D0 (en) 1991-01-28
IL95327A (en) 1995-10-31
EP0417473B1 (de) 1993-09-15

Similar Documents

Publication Publication Date Title
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
NO903532D0 (no) Fremgangsmaate for behandling av kardiell, saavel som vaskulaer hypertropi og hyperplasi.
SE8503680D0 (sv) Indolderivat
DK51986A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som insecticide midler
FI913478A0 (fi) Diazinderivat.
DK490486D0 (da) Sammensaetning til behandling af atherosclerose, tromboser og/eller perifere karsygdomme
ES2123652T3 (es) 7-(2-aminoetil)-benzotiazolonas.
NO840048L (no) Disubstituerte prolinderivater, fremgangsmaate til deres fremstilling og deres anvendelse
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
NO952205L (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
NO891703L (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
DK0429370T3 (da) Hiditl ukendte thiophenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO169176C (no) Tyroninderivater, og deres fremstillig og anvendelse
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
ES2040750T3 (es) Un procedimiento para la preparacion de un derivado de isoquinolinol.
NO880405D0 (no) Fremgangsmaate til fremstilling av 3-fenyl-7h-tiazolo-/3,2-b//1,2,4/-tiazine-7-oner.
DK0635491T3 (da) (Thia)cycloalkylab indoler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse forbindelser.
FI944967L (fi) Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi
DK572189A (da) Substituerede adeninderivater og farmaceutisk praeparat indeholdende dem

Legal Events

Date Code Title Description
MK1K Patent expired